Lentiviral-mediated transcriptional targeting of dendritic cells for induction of T cell tolerance in vivo

Journal of Immunology

Volumn 181, Issue 7, 2008, Pages 4495-4506

  Dresch, Christiane ^a,c   Edelmann, Stephanie L ^a   Marconi, Peggy ^b   Brocker, Thomas ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF FERRARA   (Italy)

^c UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

LENTIVIRUS VECTOR; DC STAMP PROTEIN, MOUSE; DC-STAMP PROTEIN, MOUSE; INSULIN; MEMBRANE PROTEIN; NERVE PROTEIN; OVALBUMIN; UNCLASSIFIED DRUG;

5' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL BASED GENE THERAPY; CELL SPECIFICITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DIABETES MELLITUS; GENE EXPRESSION; IMMUNOLOGICAL TOLERANCE; IN VIVO STUDY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; ANIMAL; C57BL MOUSE; CELL LINE; CELL STRAIN 3T3; GENE TARGETING; GENE VECTOR; GENETIC TRANSCRIPTION; GENETICS; HUMAN; IMMUNOLOGY; LENTIVIRINAE; LYMPHOCYTE ACTIVATION; METABOLISM; METHODOLOGY; PROMOTER REGION; RADIATION CHIMERA; RAT; T LYMPHOCYTE SUBPOPULATION; TRANSGENIC MOUSE; VIROLOGY; VIRUS DNA CELL DNA INTERACTION;

ANIMALS; CELL LINE; DENDRITIC CELLS; GENE TARGETING; GENETIC VECTORS; HUMANS; IMMUNE TOLERANCE; INSULIN; LENTIVIRUS; LYMPHOCYTE ACTIVATION; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NERVE TISSUE PROTEINS; NIH 3T3 CELLS; OVALBUMIN; PROMOTER REGIONS, GENETIC; RADIATION CHIMERA; RATS; T-LYMPHOCYTE SUBSETS; TRANSCRIPTION, GENETIC; VIRUS INTEGRATION;

EID: 58149311504     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.7.4495     Document Type: Article

References (47)

1. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392: 245-252.
2. Reis e Sousa, C. 2006. Dendritic cells in a mature age. Nat. Rev. Immunol. 6: 476-483.
3. Steinman, R. M., D. Hawiger, and M. C. Nussenzweig. 2003. Tolerogenic dendritic cells. Annu. Rev. Immunol. 21: 685-711.
4. Steinman, R. M., and M. C. Nussenzweig. 2002. Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc. Natl. Acad. Sci. USA 99: 351-358. (Pubitemid 34060366)
5. + regulatory T cells in vivo in humans. Blood 100: 174-177.
6. Dhodapkar, M. V., R. M. Steinman, J. Krasovsky, C. Munz, and N. Bhardwaj. 2001. Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J. Exp. Med. 193: 233-238.
7. Rea, D., F. H. Schagen, R. C. Hoeben, M. Mehtali, M. J. Havenga, R. E. Toes, C. J. Melief, and R. Offringa. 1999. Adenoviruses activate human dendritic cells without polarization toward a T-helper type 1-inducing subset. J. Virol. 73: 10245-10253.
8. Tan, P. H., S. C. Beutelspacher, Y. H. Wang, M. O. McClure, M. A. Ritter, G. Lombardi, and A. J. George. 2005. Immunolipoplexes: an efficient, nonviral alternative for transfection of human dendritic cells with potential for clinical vaccination. Mol. Ther. 11: 790-800.
9. Miller, G., S. Lahrs, V. G. Pillarisetty, A. B. Shah, and R. P. DeMatteo. 2002. Adenovirus infection enhances dendritic cell immunostimulatory properties and induces natural killer and T-cell-mediated tumor protection. Cancer Res. 62: 5260-5266. (Pubitemid 35024600)
10. + T cell-dependent elimination of dendritic cells in vivo limits the induction of antitumor immunity. J. Immunol. 164: 3095-3101.
11. Bonifaz, L., D. Bonnyay, K. Mahnke, M. Rivera, M. C. Nussenzweig, and R. M. Steinman. 2002. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance. J. Exp. Med. 196: 1627-1638. (Pubitemid 36026474)
12. Hawiger, D., K. Inaba, Y. Dorsett, M. Guo, K. Mahnke, M. Rivera, J. V. Ravetch, R. M. Steinman, and M. C. Nussenzweig. 2001. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. Med. 194: 769-779. (Pubitemid 32983013)
13. Dudziak, D., A. O. Kamphorst, G. F. Heidkamp, V. R. Buchholz, C. Trumpfheller, S. Yamazaki, C. Cheong, K. Liu, H. W. Lee, C. G. Park, et al. 2007. Differential antigen processing by dendritic cell subsets in vivo. Science 315: 107-111. (Pubitemid 46196991)
14. Redmond, W. L., and L. A. Sherman. 2005. Peripheral tolerance of CD8 T lymphocytes. Immunity 22: 275-284.
15. Gallegos, A. M., and M. J. Bevan. 2006. Central tolerance: good but imperfect. Immunol. Rev. 209: 290-296.
16. Gallegos, A. M., and M. J. Bevan. 2004. Central tolerance to tissue-specific antigens mediated by direct and indirect antigen presentation. J. Exp. Med. 200: 1039-1049.
17. + regulatory T cells in human thymus. Nature 436: 1181-1185.
18. Barnden, M. J., J. Allison, W. R. Heath, and F. R. Carbone. 1998. Defective TCR expression in transgenic mice constructed using cDNA-based α- and β-chain genes under the control of heterologous regulatory elements. Immunol. Cell Biol. 76: 34-40.
19. Hogquist, K. A., S. C. Jameson, W. R. Heath, J. L. Howard, M. J. Bevan, and F. R. Carbone. 1994. T cell receptor antagonist peptides induce positive selection. Cell 76: 17-27. (Pubitemid 24035278)
20. Kurts, C., R. M. Sutherland, G. Davey, M. Li, A. M. Lew, E. Blanas, F. R. Carbone, J. F. Miller, and W. R. Heath. 1999. CD8 T cell ignorance or tolerance to islet antigens depends on antigen dose. Proc. Natl. Acad. Sci. USA 96: 12703-12707. (Pubitemid 29513566)
21. Lois, C., E. J. Hong, S. Pease, E. J. Brown, and D. Baltimore. 2002. Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science 295: 868-872. (Pubitemid 34118370)
22. Diebold, S. S., M. Cotten, N. Koch, and M. Zenke. 2001. MHC class II presentation of endogenously expressed antigens by transfected dendritic cells. Gene Ther. 8: 487-493. (Pubitemid 32266404)
23. Hartgers, F. C., J. L. Vissers, M. W. Looman, C. van Zoelen, C. Huffine, C. G. Figdor, and G. J. Adema. 2000. DC-STAMP, a novel multimembranespanning molecule preferentially expressed by dendritic cells. Eur. J. Immunol. 30: 3585-3590. (Pubitemid 32005231)
24. Eleveld-Trancikova, D., V. Triantis, V. Moulin, M. W. Looman, M. Wijers, J. A. Fransen, A. A. Lemckert, M. J. Havenga, C. G. Figdor, R. A. Janssen, and G. J. Adema. 2005. The dendritic cell-derived protein DC-STAMP is highly conserved and localizes to the endoplasmic reticulum. J. Leukocyte Biol. 77: 337-343. (Pubitemid 40289563)
25. Yee, J. K., J. C. Moores, D. J. Jolly, J. A. Wolff, J. G. Respess, and T. Friedmann. 1987. Gene expression from transcriptionally disabled retroviral vectors. Proc. Natl. Acad. Sci. USA 84: 5197-5201.
26. Yu, S. F., T. von Ruden, P. W. Kantoff, C. Garber, M. Seiberg, U. Ruther, W. F. Anderson, E. F. Wagner, and E. Gilboa. 1986. Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells. Proc. Natl. Acad. Sci. USA 83: 3194-3198.
27. + splenic dendritic cells. Blood 103: 2668-2676.
28. Kurts, C., M. Cannarile, I. Klebba, and T. Brocker. 2001. Dendritic cells are sufficient to cross-present self-antigens to CD8 T cells in vivo. J. Immunol. 166: 1439-1442. (Pubitemid 32114619)
29. Shortman, K., and S. H. Naik. 2007. Steady-state and inflammatory dendritic-cell development. Nat. Rev. Immunol. 7: 19-30.
30. + T cells undergoing peripheral deletion in response to cross-presentation of self-antigen. J. Exp. Med. 194: 707-717.
31. Brehm, M. A., K. A. Daniels, and R. M. Welsh. 2005. Rapid production of TNF-α following TCR engagement of naive CD8 T cells. J. Immunol. 175: 5043-5049.
32. Lauterbach, H., C. Ried, A. L. Epstein, P. Marconi, and T. Brocker. 2005. Reduced immune responses after vaccination with a recombinant herpes simplex virus type 1 vector in the presence of antiviral immunity. J. Gen. Virol. 86: 2401-2410. (Pubitemid 41167587)
33. Curtsinger, J. M., D. C. Lins, and M. F. Mescher. 2003. Signal 3 determines tolerance versus full activation of naive CD8 T cells: dissociating proliferation and development of effector function. J. Exp. Med. 197: 1141-1151.
34. Lauterbach, H., K. M. Kerksiek, D. H. Busch, E. Berto, A. Bozac, P. Mavromara, R. Manservigi, A. L. Epstein, P. Marconi, and T. Brocker. 2004. Protection from bacterial infection by a single vaccination with replication-deficient mutant herpes simplex virus type 1. J. Virol. 78: 4020-4028. (Pubitemid 38437208)
35. Gordon, S., and P. R. Taylor. 2005. Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 5: 953-964.
36. Tsokos, G. C., and G. T. Nepom. 2000. Gene therapy in the treatment of autoimmune diseases. J. Clin. Invest. 106: 181-183. (Pubitemid 30483120)
37. Ally, B. A., T. S. Hawley, K. J. McKall-Faienza, T. M. Kundig, S. U. Oehen, H. Pircher, R. G. Hawley, and P. S. Ohashi. 1995. Prevention of autoimmune disease by retroviral-mediated gene therapy. J. Immunol. 155: 5404-5408.
38. Kang, Y., M. Melo, E. Deng, R. Tisch, M. El-Amine, and D. W. Scott. 1999. Induction of hyporesponsiveness to intact foreign protein via retroviral-mediated gene expression: the IgG scaffold is important for induction and maintenance of immune hyporesponsiveness. Proc. Natl. Acad. Sci. USA 96: 8609-8614. (Pubitemid 29354839)
39. Bagley, J., C. Tian, D. H. Sachs, and J. Iacomini. 2002. Induction of T-cell tolerance to an MHC class I alloantigen by gene therapy. Blood 99: 4394-4399. (Pubitemid 34627206)
40. Bagley, J., J. L. Bracy, C. Tian, E. S. Kang, and J. Iacomini. 2002. Establishing immunological tolerance through the induction of molecular chimerism. Front. Biosci. 7: d1331-d1337.
41. Hacein-Bey-Abina, S., C. Von Kalle, M. Schmidt, M. P. McCormack, N. Wulffraat, P. Leboulch, A. Lim, C. S. Osborne, R. Pawliuk, E. Morillon, et al. 2003. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302: 415-419. (Pubitemid 37296260)
42. Li, Z., U. Modlich, and C. Baum. 2004. Safety and efficacy in retrovirally modified haematopoietic cell therapy. Best Pract. Res. Clin. Haematol. 17: 493-503. (Pubitemid 39462579)
43. Schuler, G., B. Schuler-Thurner, and R. M. Steinman. 2003. The use of dendritic cells in cancer immunotherapy. Curr. Opin. Immunol. 15: 138-147. (Pubitemid 36287518)
44. Hugues, S., L. Fetler, L. Bonifaz, J. Helft, F. Amblard, and S. Amigorena. 2004. Distinct T cell dynamics in lymph nodes during the induction of tolerance and immunity. Nat. Immunol. 5: 1235-1242. (Pubitemid 41057738)
45. Lindemann, C., A. J. Schilz, B. Emons, C. Baum, R. Low, A. A. Fauser, K. Kuehlcke, and H. G. Eckert. 2002. Down-regulation of retroviral transgene expression during differentiation of progenitor-derived dendritic cells. Exp. Hematol. 30: 150-157. (Pubitemid 34081226)
46. Bouillet, P., J. F. Purton, D. I. Godfrey, L. C. Zhang, L. Coultas, H. Puthalakath, M. Pellegrini, S. Cory, J. M. Adams, and A. Strasser. 2002. BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes. Nature 415: 922-926. (Pubitemid 34174755)
47. + T cell tolerance in vivo. Immunity 28: 521-532.